| Year |
Citation |
Score |
| 2023 |
Yapp C, Nirmal AJ, Zhou F, Maliga Z, Llopis PM, Murphy GF, Lian CG, Danuser G, Santagata S, Sorger PK. Multiplexed 3D Analysis of Cell Plasticity and Immune Niches in Melanoma. Biorxiv : the Preprint Server For Biology. PMID 38014052 DOI: 10.1101/2023.11.10.566670 |
0.503 |
|
| 2022 |
Chowdhury R, Bouatta N, Biswas S, Floristean C, Kharkar A, Roy K, Rochereau C, Ahdritz G, Zhang J, Church GM, Sorger PK, AlQuraishi M. Publisher Correction: Single-sequence protein structure prediction using a language model and deep learning. Nature Biotechnology. 40: 1692. PMID 36253538 DOI: 10.1038/s41587-022-01556-z |
0.673 |
|
| 2022 |
Chowdhury R, Bouatta N, Biswas S, Floristean C, Kharkare A, Roye K, Rochereau C, Ahdritz G, Zhang J, Church GM, Sorger PK, AlQuraishi M. Single-sequence protein structure prediction using a language model and deep learning. Nature Biotechnology. PMID 36192636 DOI: 10.1038/s41587-022-01432-w |
0.685 |
|
| 2022 |
Doherty LM, Mills CE, Boswell SA, Liu X, Hoyt CT, Gyori B, Buhrlage SJ, Sorger PK. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Elife. 11. PMID 35737447 DOI: 10.7554/eLife.72879 |
0.659 |
|
| 2021 |
Patiño-Galindo JÁ, Filip I, Chowdhury R, Maranas CD, Sorger PK, AlQuraishi M, Rabadan R. Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2. Genome Medicine. 13: 124. PMID 34362430 DOI: 10.1186/s13073-021-00943-6 |
0.698 |
|
| 2019 |
Rashid R, Gaglia G, Chen YA, Lin JR, Du Z, Maliga Z, Schapiro D, Yapp C, Muhlich J, Sokolov A, Sorger P, Santagata S. Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer. Scientific Data. 6: 323. PMID 31848351 DOI: 10.1038/S41597-019-0332-Y |
0.312 |
|
| 2019 |
Gerosa L, Chidley C, Froehlich F, Sanchez G, Lim SK, Muhlich J, Chen J, Baker GJ, Schapiro D, Shi T, Yi L, Nicora CD, Qian W, Wiley HS, Sorger P. Abstract LB-B09: ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cells Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-Lb-B09 |
0.352 |
|
| 2018 |
Mills C, Hafner M, Subramanian K, Chen C, Chung M, Boswell S, Everley R, Walmsley C, Juric D, Sorger P. Abstract PD1-12: Omics profiling of CDK4/6 inhibitors reveals functionally important secondary targets of abemaciclib Cancer Research. 16. DOI: 10.1158/1538-7445.Sabcs18-Pd1-12 |
0.369 |
|
| 2018 |
Hafner M, Mills C, Subramanian K, Chen C, Boswell S, Everley R, Juric D, Sorger P. Abstract PD4-02: Advantageous polypharmacology of abemaciclib revealed by omics profiling of CDK4/6 inhibitors Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd4-02 |
0.36 |
|
| 2017 |
Werbin JL, Avendaño MS, Becker V, Jungmann R, Yin P, Danuser G, Sorger PK. Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane. Scientific Reports. 7: 12150. PMID 28939861 DOI: 10.1038/S41598-017-12257-Y |
0.71 |
|
| 2017 |
Lin J, Izar B, Hawthorne S, Nordberg J, Kaldjian E, Sorger P. Abstract B21: Probing tumor heterogeneity and immune infiltration with Cyclic Immunofluorescence (CycIF), a robust, multiplexed imaging method Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-B21 |
0.313 |
|
| 2017 |
Mills C, Hafner M, Sorger P. Abstract P4-08-02: Integration of transcriptomic, proteomic and drug response data in triple negative breast cancer cell lines and PDX models Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P4-08-02 |
0.349 |
|
| 2017 |
Rao S, Li T, Everley R, Du G, Sorger P, Gray N. Abstract 1222: Developing kinase inhibitors with polypharmacological profiles for the treatment of resistant cancers Cancer Research. 77: 1222-1222. DOI: 10.1158/1538-7445.Am2017-1222 |
0.344 |
|
| 2016 |
Mills C, Andrews D, Sorger P. Abstract 203: Single cell imaging of kinase inhibitor-induced effects in breast cancer cell lines Cancer Research. 76: 203-203. DOI: 10.1158/1538-7445.Am2016-203 |
0.342 |
|
| 2015 |
Hafner M, Niepel M, Duan Q, Paull E, Stuart J, Subramanian A, Ma'ayan A, Sorger P. Abstract B20: Transcriptional landscape of drug response guides the design of specific and potent drug combinations Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B20 |
0.349 |
|
| 2013 |
Marco E, Dorn JF, Hsu PH, Jaqaman K, Sorger PK, Danuser G. S. cerevisiae chromosomes biorient via gradual resolution of syntely between S phase and anaphase. Cell. 154: 1127-39. PMID 23993100 DOI: 10.1016/J.Cell.2013.08.008 |
0.475 |
|
| 2013 |
Thurber GM, Yang KS, Reiner T, Kohler RH, Sorger P, Mitchison T, Weissleder R. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo. Nature Communications. 4: 1504. PMID 23422672 DOI: 10.1038/Ncomms2506 |
0.365 |
|
| 2013 |
Gujral TS, Karp RL, Finski A, Chan M, Schwartz PE, MacBeath G, Sorger P. Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays. Oncogene. 32: 3470-6. PMID 22945653 DOI: 10.1038/Onc.2012.378 |
0.355 |
|
| 2013 |
Sarosiek KA, Bachman J, Montero J, Patel L, Sims JJ, Chi X, Andrews DW, Sorger P, Letai A. Abstract 1713: BAX and BAK are preferentially activated by BIM and BID, respectively, affecting clinical chemotherapy response. Cancer Research. 73: 1713-1713. DOI: 10.1158/1538-7445.Am2013-1713 |
0.312 |
|
| 2013 |
Florian S, Chittajallu DR, Kohler RH, Orth JD, Sorger PK, Weissleder R, Danuser G, Mitchison TJ. Abstract A297: Microtubule targeting antimitotic drugs induce a lower mitotic arrest than clinically less effective antimitotic Eg5 inhibitors in mouse xenografts. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A297 |
0.495 |
|
| 2013 |
Schoeberl B, Pace E, Niepel M, Hafner M, Chai D, Sorger P. Abstract P6-05-01: Basal and induced receptor profiles cluster cell lines into subtypes and predict drug response in a panel of breast cancer lines Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-05-01 |
0.309 |
|
| 2012 |
Schmidt U, Werbin JL, Sorger PK, Danuser G. Single Molecule Counting using STORM/PALM Biophysical Journal. 102: 384a-385a. DOI: 10.1016/J.Bpj.2011.11.2104 |
0.706 |
|
| 2010 |
Sorger P, Spencer S, Gaudet S, Aldridge B, D F. Abstract ES6-2: Cell to Cell Variability in the Responses of Tumor Cells to Death Ligands and Other Anti-Cancer Drugs Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Es6-2 |
0.301 |
|
| 2009 |
Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, Cufer T, Ferrell J, Galas D, Gallahan D, Gatenby R, ... ... Sorger P, et al. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008). Molecular Oncology. 3: 9-17. PMID 19383362 DOI: 10.1016/J.Molonc.2008.11.003 |
0.311 |
|
| 2007 |
Jaqaman K, Dorn JF, Marco E, Sorger PK, Danuser G. Phenotypic clustering of yeast mutants based on kinetochore microtubule dynamics. Bioinformatics (Oxford, England). 23: 1666-73. PMID 17483508 DOI: 10.1093/Bioinformatics/Btm230 |
0.475 |
|
| 2006 |
Jaqaman K, Dorn JF, Jelson GS, Tytell JD, Sorger PK, Danuser G. Comparative autoregressive moving average analysis of kinetochore microtubule dynamics in yeast. Biophysical Journal. 91: 2312-25. PMID 16940476 DOI: 10.1529/Biophysj.106.080333 |
0.471 |
|
| 2005 |
Dorn JF, Jaqaman K, Rines DR, Jelson GS, Sorger PK, Danuser G. Yeast kinetochore microtubule dynamics analyzed by high-resolution three-dimensional microscopy. Biophysical Journal. 89: 2835-54. PMID 16192284 DOI: 10.1529/Biophysj.104.058461 |
0.472 |
|
| 2003 |
Thomann D, Dorn J, Sorger PK, Danuser G. Automatic fluorescent tag localization II: Improvement in super-resolution by relative tracking. Journal of Microscopy. 211: 230-48. PMID 12950472 DOI: 10.1046/J.1365-2818.2003.01223.X |
0.484 |
|
| 2002 |
Thomann D, Rines DR, Sorger PK, Danuser G. Automatic fluorescent tag detection in 3D with super-resolution: application to the analysis of chromosome movement. Journal of Microscopy. 208: 49-64. PMID 12366597 DOI: 10.1046/J.1365-2818.2002.01066.X |
0.496 |
|
| Show low-probability matches. |